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Abstract 31 
This study evaluated different gilt vaccination protocols against Mycoplasma (M.) 32 
hyopneumoniae at acclimation and their effect on the genetic diversity. A total of 180 M. 33 
hyopneumoniae naïve gilts were selected 1 week post-entry (wpe) at the acclimation barn 34 
in a clinically affected M. hyopneumoniae farm. Gilts were distributed according to the 35 
M. hyopneumoniae antibodies levels into three different vaccination schedules: A) four 36 
doses of a M. hyopneumoniae commercial vaccine at 2, 4, 6 and 8 wpe; B) two vaccine 37 
doses at 2 and 6 wpe and PBS at 4 and 8 wpe; and C) four PBS doses at the same wpe. 38 
Detection of M. hyopneumoniae (rt-PCR) and antibodies (ELISA) were assessed in gilts 39 
at 1, 14, 27 and 34 wpe and in 6 of their piglets at weaning. rt-PCR positive gilts were 40 
detected at 14 wpe, being the proportion significantly lower in groups A and B (3/120, 41 
3%) than C (27/60, 45%). Seroconversion was detected at 14 wpe, showing significant 42 
differences in percentage of inhibition (PI) between groups A (median 4.9, range 3.1-43 
19.9) and B (5.5, 3.7-13.5), and C (14.3, 3.3-53.2). Gilts remained seropositive over the 44 
study; significant differences in PI were detected between groups A and B versus C. 45 
Piglets were rt-PCR negative; proportion of seropositive piglets coming from vaccinated 46 
gilts was significantly higher than the non-vaccinated group. M. hyopneumoniae 47 
characterization showed high variability. Hence, gilt vaccination with 2 or 4 doses 48 
significantly decreased the pathogen infectious pressure, variability, and provided high 49 
antibody levels to gilts and their offspring. 50 
51 
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1. Introduction 52 
Mycoplasma hyopneumoniae (M. hyopneumoniae) is the primary agent of enzootic 53 
pneumonia (EP), a chronic respiratory disease that affects mainly growing and finishing 54 
pigs. This disease is an important concern to the swine industry due to economic losses 55 
generated by a reduction of performance and growth, as well as antimicrobial treatments 56 
and control/eradication costs (Thacker and Minion, 2012). 57 
Mycoplasma hyopneumoniae is transmitted by direct contact between infected and 58 
susceptible animals (Maes et al., 1996). Since intrauterine infection has not been 59 
described, piglets are considered M. hyopneumoniae-free at birth. Hence, the first 60 
exposure to M. hyopneumoniae would occur during  the lactation period when piglets are 61 
in contact with a shedding dam (Sibila et al., 2007). Taking into account that piglet 62 
colonization at weaning has been correlated with M. hyopneumoniae prevalence and 63 
severity of lung lesions in growing-finishing pigs (Fano et al., 2007; Sibila et al., 2007), a 64 
reduction of transmission between dams and offspring during the lactation period, 65 
together with the piglet vaccination, seem to be a key point for disease control. 66 
Additionally, bacterial shedding of gilts and young sows seems to be higher than that of 67 
older parity sows (Boonsoongnern et al., 2012). Thus, an adequate gilt acclimation 68 
focused on decreasing the bacterial shedding at first farrowing should aid in reducing 69 
piglet colonization at weaning age (Pieters and Fano, 2016). 70 
Information on gilt acclimation practices is limited. In Europe, a previous study based 71 
on a survey identified the vaccination against M. hyopneumoniae as the acclimation 72 
strategy most used by the participants (Garza-Moreno et al., 2017). Likewise, M. 73 
hyopneumoniae gilt vaccination has been described as the most common practice in US 74 
(Fano and Payne, 2015). Recently, a review compared the acclimation practices carried 75 
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out in Europe and America (Mexico and USA), being  vaccination the main strategy used 76 
as well (Garza-Moreno et al., 2018).  77 
Gilt vaccination schedules against M. hyopneumoniae can be variable among farms in 78 
terms of number of administered vaccine doses and application timings. Thus, gilt 79 
vaccination protocols based on multiple doses are becoming commonly used in some 80 
parts of the world (Alfonso et al., 2004; Yeske et al., 2007; Garza-Moreno et al., 2018). 81 
Nevertheless, no information regarding the efficacy of multiple gilt vaccination during 82 
the acclimation period is available in the literature. Therefore, this study aimed to 83 
compare different gilt vaccination schedules on the M. hyopneumoniae gilt 84 
seroconversion and shedding at different times post-vaccination, as well as piglet 85 
antibody detection and colonization at weaning. Moreover, this study also investigated 86 
the potential effect of vaccination on the genetic diversity of M. hyopneumoniae within 87 
the studied farm.  88 
 89 
2. Material and methods 90 
2.1. Farm management and housing conditions 91 
A conventional M. hyopneumoniae positive, clinically affected (Garza-Moreno et al., 92 
2018) farrow-to-finish farm introducing external negative and own positive replacement 93 
gilts was selected. The selected farm had a gilt development unit (GDU) for acclimation 94 
with a duration approximately of 10 weeks, which followed all-in/all-out management 95 
practices. After acclimation, external and own replacement gilt batches were moved to 96 
oestrus detection and synchronization unit (DSU) and were allocated sharing pens (60 97 
gilts per pen). At the DSU, gilt oestrus was synchronized and gilts were divided in 98 
weekly batches of 90 gilts according to oestrus detection time. Gilts were artificially 99 
inseminated at the second oestrus and pregnancy diagnosis was performed 4 weeks after 100 
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insemination. Once pregnancy was confirmed, pregnant gilts were moved to the gestation 101 
unit  and housed in pens (60 gilts/pen). Finally, one week previous to delivery, gilts were 102 
moved to the farrowing units. In these facilites, with continuous flow and weekly batch 103 
management, a total of 50 gilts and sows of different parities were housed.  104 
2.2.  M. hyopneumoniae infectious status previous to the start of the study 105 
To confirm M. hyopneumoniae gilt infection during acclimation, laryngeal swabs (LS) 106 
from a total of 20 gilts (10 gilts/batch) showing clinical signs of dry coughing from two 107 
previous batches of own replacement (FS1 and FS2) were collected at 14 weeks post-108 
entry (wpe) in the GDU. In these samplings, 19 out of 20 (95%) gilts were M. 109 
hyopneumoniae positive by real-time PCR (rt-PCR), being 10 out of 10 (100%) positive 110 
gilts in FS1 and 9 out of 10 (90%) in FS2. The Ct values  varied from 30.7 to 36.9 in FS1 111 
and from 27.5 to 36.9 in FS2.  112 
2.3.   Animal selection and study design 113 
Blood samples (BS) and LS from a total of 180 six month-old  gilts coming from an 114 
external M. hyopneumoniae negative farm were collected at 1 wpe at the GDU (Figure 1). 115 
Laryngeal swabs and BS were tested for detection of the pathogen and the antibodies 116 
against it, respectively. Afterwards, gilts were randomly divided into three groups (A: 117 
four vaccine doses; B: two vaccine doses and C: no vaccinated) balanced according to M. 118 
hyopneumoniae antibodies measured by ELISA percentage of inhibition (PI). Animals 119 
received intramuscularly 2 mL per dose of a M. hyopneumoniae commercial vaccine 120 
(Hyogen®, CEVA Santé Animale, Libourne, Cedex, France), indicated for pigs from 3 121 
weeks onwards, and/or 2 mL of phosphate-buffered saline (PBS) according to their 122 
experimental group and time points (Table 1). 123 
Gilts included in this study entered at the DSU splitted into two batches (n=90 124 
each batch) separated by one week. Piglets were ear tagged at birth according to their 125 
8 
 
maternal treatment and cross-fostering was allowed only between sows within the same 126 
treatment. One day prior to weaning, six randomly selected piglets per sow were 127 
monitored and sampled. No antimicrobials against M. hyopneumoniae were administrated 128 
to gilts and piglets under study.  129 
Study procedures were approved by the Animal Experimentation Ethics 130 
Committee of the Generalitat de Catalunya (Departament de Territori i Sostenibilitat, 131 
Direcció General de Polítiques Ambientals i Medi Natural; Reference 9336). 132 
2.4.  Sample collection and processing 133 
Blood samples and LS were collected from gilts at 1, 14, 27 and 34 wpe, and from 6 134 
piglets of each of them at weaning (Figure 1). Once in the laboratory, blood was 135 
centrifuged at 1500 g for 10 min at 4ºC and sera was aliquoted and stored at -20ºC until 136 
used. Laryngeal swabs were re-suspended in 1 mL of PBS, vortexed, and stored at -20ºC 137 
until DNA extraction was performed.  138 
2.5. Detection of M. hyopneumoniae-specific antibodies in serum 139 
Sera were tested in duplicate for the presence of antibodies against M. hyopneumoniae by 140 
means of a commercial competitive ELISA (IDEIA™ M. hyopneumoniae, EIA kit, 141 
Oxoid, Thermo Fisher Scientific, UK). ELISA results were expressed as percentage of 142 
inhibition (PI). The PI was calculated considering the mean optical density (OD) of each 143 
sample and the buffer control following the formula: % PI = 100*(mean sample OD/ 144 
mean buffer control OD). Samples with PI < 50% were considered to be positive, 145 
whereas doubtful (PI from 50 to 64%) and negative samples (PI≥65%) were classified as 146 
negative. PI median and ranges of tested samples were calculated.  147 
2.6. DNA extraction and M. hyopneumoniae detection by real time PCR 148 
DNA was extracted from 200 μL of LS suspension using MagMax™ DNA Multi-Sample 149 
Kit (Life Technologies, USA) according to the manufacturer’s instructions, on the 150 
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BioSprint 96 workstation (Qiagen GmbH, Germany). Two different positive extraction 151 
controls were used in each extraction: a LS spiked with M. hyopneumoniae strain 11 152 
(ATCC®25095™) and a commercial internal positive control (Xeno™, included in 153 
VetMax™-Plus qPCR Master Mix kit). Negative controls (PBS) were also included to 154 
assess potential contamination during extraction. 155 
Extracted DNA was tested by a commercial real time PCR (rt-PCR) for M. 156 
hyopneumoniae detection: VetMax™-Plus qPCR Master Mix (Life Technologies, USA) 157 
and VetMax™ M. hyopneumoniae Reagents (Life Technologies, USA), according to the 158 
manufacturer’s instructions. Rt-PCR runs were carried out in ABI PRISM® 7500 159 
machine (Applied Biosystems, Singapore). The rt-PCR threshold was set at 10% of the 160 
maximum fluorescence value of the commercial DNA positive control. Samples with 161 
cycle threshold (Ct) values equal or lower than 40 were considered positive. Ct ranges 162 
were calculated considering only rt-PCR positive samples.  163 
2.7. M. hyopneumoniae genetic variability 164 
Positive rt-PCR LS were genotyped by the Sanger sequencing method and the variable 165 
number of tandem repeats (VNTR) of three loci (p97, p146 and h1) were counted. 166 
Moreover, the reference strain (RF) 11 (ATCC® 25934™) was also included as technique 167 
positive control. Primers used were previously described by Vranckx et al., (2011). These 168 
three loci were individually amplified in a final volume of 50 μL. Reaction mixtures 169 
contained 1X PCR Buffer, 1.5 mM MgCl2, 0.2mM each deoxynucleotide triphosphate, 1 170 
µL of each primer, 0.03U/µL U of GoTaq® G2 Flexi DNA Polymerase (Promega, 171 
Madison, USA) and, finally, 6µL of extracted DNA dilution (1:10). Cycling conditions 172 
were 4 min at 94°C, followed by 35 cycles of 30 s at 94°C, 30 s at 53°C and 30 s at 72°C, 173 
then a final extension step of 7 min at 72°C. The typing PCR products were analysed by 174 
electrophoresis on 2% agarose gel in Tris-Acetate-EDTA (TAE)-buffer and stained with 175 
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ethidium bromide. These PCR products were purified by ExoSAP-IT® (Isogen Life 176 
Science, The Netherlands) according to manufacturer’s instructions and sequenced using 177 
a ABI PRISM 3130xl (Applied Biosystems, Singapore) genetic analyser.  178 
Nucleotide sequences were aligned and translated to aminoacid sequences using 179 
FingerPrinting II Informatix software (Applied Maths, Saint-Martens-Latem, Belgium). 180 
VNTR per each locus were counted and a typing variant profile (TP) was assigned 181 
according to the combination of the three loci. The TP was considered different when the 182 
combination of VNTR per each locus was unique. A minimum spanning tree (MST) was 183 
also constructed to visualize the similarity among TP. 184 
2.8. Statistical analyses 185 
Bivariate analysis using the Kruskal-Wallis test was applied for median comparison of PI 186 
among gilt groups (A, B, and C) at different sampling points. The homogeneity of PI 187 
values in each group through the study was evaluated by F values. The Chi square test 188 
was used to evaluate the proportion of positive rt-PCR samples between treatments at 189 
different sampling points. When significant results were obtained, a posteriori contrast 190 
analysis 2 to 2 was performed. Post hoc pairwise comparisons were computed using 191 
Tukey's Honestly Significant Difference. Additionally, a linear mixed model was used to 192 
assess the effect of different gilt vaccination programs on piglet colonization and humoral 193 
immunity at weaning, considering sow as a random effect. Statistical analyses were 194 
performed with SAS v9.4 (SAS Institute Inc., Cary, NC, USA). The significance level 195 
was set to p<0.05. 196 
 197 
3. Results 198 
3.1 Detection of antibodies against M. hyopneumoniae in gilts and piglets. 199 
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Studied gilts were seronegative at 1 wpe (Table 2, Figure 2). At 14 wpe all gilts with the 200 
exception of one in group C had seroconverted (179/180, 99.4%). By 27 wpe, the number 201 
of gilts were reduced from 180 to 152 (52, 49, and 51 gilts in groups A, B and C, 202 
respectively) since 28 gilts were culled (due to lack of pregnancy and lameness, mainly). 203 
From 146 gilts (49, 47, and 50 gilts in groups A, B and C, respectively)  that reached  one 204 
week prior to farrowing sampling (34 wpe), all vaccinated gilts (groups A and B) 205 
remained seropositive, whereas the percentage of non-vaccinated seropositive gilts was 206 
slightly lower (44/50, 88.0%). Statistical differences (p<0.05) in terms of proportion of 207 
seropositive gilts among vaccinated (A and B) and non-vaccinated (C) groups were 208 
detected at 27 and 34 wpe. 209 
Mean PI values (±SD) for each group at different sampling time points are 210 
detailed in Table 2. The PI values were statistically different (p<0.05) between 211 
vaccinated (A and B) and non-vaccinated (C) groups at 14, 27 and 34 wpe (Table 2; 212 
Figure 2). Statistical differences (p<0.05) among all three groups (A, B and C) were 213 
detected in terms of PI at 14 wpe, showing differences between four and two vaccine 214 
doses. The F values showed statistical higher homogeneity of IP values (Figure 2) 215 
through this study in vaccinated group A (F=1.27) compared to group B (F=3.94) and C 216 
(F=5.49). 217 
A total of 744 piglets (252 from gilts of group A [n=42], 252 from gilts of group 218 
B [n=42] and 240 from gilts of group C [n=40]) born to the 124 gilts that reached 219 
farrowing were sampled one day prior to weaning. The differences in the proportion of 220 
seropositive and PI of piglets from vaccinated and non-vaccinated gilts were statistically 221 
significant. Additionally, a higher number of seropositive piglets coming from gilts from 222 
group A was detected compared to the ones from group B (Table 2). A total of 229 223 
piglets were seronegative (30.8%), where 23 (10%) of them came from seronegative non-224 
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vaccinated sows (group C) and the remaining 206 (22 [9.6%], 52 [22.7%] and 132 [57.7 225 
%] from groups A, B and C, respectively) came from seropositive sows (Table 2). 226 
3.2 M. hyopneumoniae detection in LS in gilts and piglets. 227 
M. hyopneumoniae positive shedding  gilts were detected at 14 and 27 wpe (Table 3). The 228 
proportions of rt-PCR positive gilts at 14 wpe in vaccinated groups A (1/60, 1.7%) and B 229 
(2/60, 3.3%) were significantly lower (p<0.05) compared to the non-vaccinated group C 230 
(27/60, 45%). However, no statistical differences were found between vaccinated groups 231 
(A and B) with different number of doses. The proportion of rt-PCR positive gilts was 232 
reduced at 27 wpe and only one positive gilt (1/51, 2.2%) was detected in the group C. 233 
Finally, none of the gilts was positive at 34 wpe for rt-PCR.  234 
All LS samples from piglets (n=744) were negative for M. hyopneumoniae by rt-235 
PCR. 236 
3.3 Characterization of M. hyopneumoniae genotypes through the study  237 
All rt-PCR positive samples detected into previous batches (FS1=10 and FS2=19), 14 238 
wpe (n=1 in group A, n=2 in group B and n=27 in group C) and 27 wpe (n=1 in group C) 239 
were used for M. hyopneumoniae genetic characterization. From these 50 samples, 43 240 
(86.0%) were successfully sequenced by the three selected loci (Table 4). Eleven 241 
different genotypes were detected among samples. Five TP were detected in each batch 242 
FS1 (n=20) and FS2 (n=19), although two variants (TP4 and TP5) were identified in both 243 
batches. Three variants were detected at 14 wpe, being different from those detected in 244 
previous batches (Table 4). No TP was able to be characterized from the positive gilt 245 
from group A at 14 wpe. A minimum spanning tree was generated to show the genetic 246 
variation over time (Figure 3).  247 
Regarding VNTR per each locus, the P97 locus showed limited heterogeneity due to 248 
the fact that only two VNTR (9 and 11 repeats) were identified (Table 4). The P146 locus 249 
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showed higher variability at FS1 and FS2, ranging from 38 to 47 and from 22 to 47 250 
repeats, respectively. The VNTR of P146 at 14 wpe was homologous (20 repeats) in all 251 
identified variants. For locus H1, the VNTR varied from 4 to 7 repeats. 252 
 253 
4. Discussion 254 
One of the key points to control EP within farms is the M. hyopneumoniae transmission 255 
between the dam and her piglets. Since gilts are considered the main M. hyopneumoniae 256 
shedders, acclimation strategies focused on reducing the bacterial shedding at first 257 
farrowing have been proposed (Pieters and Fano, 2016). Vaccination has been determined 258 
as the most used strategy for acclimation as well as elimination, although different 259 
number of doses and application timings are being used (Garza-Moreno et al., 2018). 260 
However, its effect on gilt shedding, humoral immune response, as well as the maternal 261 
derived immunity transfer to piglets was not assessed in any of those studies. The number 262 
of vaccine doses and the application timing that has been proposed in the past has been 2 263 
doses at 1 and 3 wpe to GDU (Yeske, 2007), or 3 doses at 55 and 220 days of age of gilts, 264 
and another last dose 2 weeks prior to farrowing (Alfonso et al., 2004). On the other 265 
hand,  the effect of sow vaccination against M. hyopneumoniae infection at 8 and 4 266 
(Grosse Beilage and Schereiber, 2005), or 5 and 3 weeks prior to farrowing (Ruiz et al., 267 
2003; Sibila et al., 2008) has been evaluated. All the three studies agreed that sow 268 
vaccination against M. hyopneumoniae enhanced levels of antibodies in vaccinated sows 269 
as well as in their piglets. In addition, Ruiz et al. (2003) and Sibila et al. (2008) 270 
concluded that sow vaccination could reduce, numerically, the prevalence of piglet 271 
colonization, whereas Grosse-Beilage and Schereiber (2005) did not evaluate this 272 
parameter. Therefore, the objective of the present study was to evaluate the effect of gilt 273 
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vaccination against M. hyopneumoniae using different vaccination programs during the 274 
acclimation period on gilt shedding, and consequently, on piglet’s colonization. 275 
 The current study used vaccination protocols based on multiple doses (four and 276 
two) since a number of field studies have hypothesized that a high number of vaccine 277 
doses could induce a strong immune response, reduce colonization, and better control the 278 
disease (Alfonso et al., 2004; Yeske, 2007). The interval between the first and booster 279 
vaccination in the present study was 2 weeks to complete the vaccination protocol within 280 
a rather usual timing of acclimation at GDU (Garza-Moreno et al., 2017). In order to 281 
minimize the effect of the previous humoral immune status, gilts were distributed into 282 
three groups according to ELISA PI values at entry. At 14 wpe, all vaccinated gilts had 283 
seroconverted, as expected with commercial vaccines. From the non-vaccinated group, all 284 
gilts but one also seroconverted, indicating that M. hyopneumoniae natural exposure 285 
occurred soon after entry. Significant differences of humoral responses in terms of PI 286 
were detected between vaccinated and non-vaccinated groups at all sampling points, as 287 
previously described by Kristensen et al. (2004) in sows. Interestingly, all vaccinated gilts 288 
remained seropositive during all study duration. On the contrary, the proportion of 289 
seropositive gilts in the non-vaccinated group decreased slightly over time (from 98% at 290 
1 wpe to 88% in both 27 and 34 wpe). These findings suggest that vaccination may 291 
provide a longer duration of humoral immunity compared to that of natural infection. 292 
Furthermore, the statistically significant differences found between animals vaccinated 293 
with four or two vaccine doses at 14 wpe suggests that repeated vaccination elicited 294 
stronger immune response (lower PI). Indeed, PI values from vaccinated gilts with four 295 
doses remained  statistically more homogeneous (lower F values) than those vaccinated 296 
with two doses followed by the non-vaccinated group, suggesting that vaccination helped 297 
homogenizing the immune status of the studied population.  298 
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A significantly higher percentage of seropositive piglets at weaning from gilts 299 
vaccinated four or two times was detected compared to those from non-vaccinated gilts. 300 
This finding is in agreement with other studies in sows (Kristensen et al., 1981; Grosse 301 
Beilage and Schereiber, 2005), fitting with the hypothesis that vaccinated gilts show 302 
higher antibody levels against M. hyopneumoniae (lower PI) than non-vaccinated gilts in 303 
colostrum. Nevertheless, no statistical differences were identified between piglets coming 304 
from gilts from groups A and B, suggesting the passive humoral transfer might be fairly 305 
independent of 2 or 4 doses applied. Additionally, 206 seronegative piglets were from 306 
seropositive sows at 34 wpe. This fact could be explained by a poor colostrum intake 307 
(Quesnel, 2011) and/or the decay of M. hyopneumoniae maternal antibodies since 308 
previous studies reported a median half-live of maternally derived antibodies of 15 days 309 
and, therefore, the amount of transferred antibodies was dependent on the dam’s 310 
serological status  (Morris et al., 1995).   311 
M. hyopneumoniae shedding was first detected at 14 wpe, with the proportion of 312 
shedding gilts significantly lower in the vaccinated than in non-vaccinated groups. This 313 
finding could be associated with the reduction of M. hyopneumoniae bacterial load by 314 
vaccination, as previously reported by Woolley et al. (2014). Moreover, an absolute 315 
reduction of shedding gilts was detected at 27 wpe in vaccinated groups, and only one 316 
non-vaccinated gilt was a shedder. M. hyopneumoniae was not detected in any studied 317 
group at 34 wpe. The fact that all gilts from the non-vaccinated group seroconverted 318 
indicates that M. hyopneumoniae infection occurred, and this probably took place in a 319 
relatively short period of time, since by 27 wpe only one gilt was detected as PCR 320 
positive. Taking this into account, gilts from this trial could have been naturally exposed 321 
to M. hyopneumoniae around 9-12 wpe, shortly after mixing them with the positive own 322 
replacement. The peak of shedding might have been reached at 14 wpe (5 weeks after this 323 
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exposure) and the complete cease of shedding would have occurred between 27 and 34 324 
wpe (18-25 weeks after exposure). The duration of gilt shedding in this study seemed to 325 
be shorter compared to a previous study that detected shedders up to 200 days post-326 
infection under experimental conditions (Pieters et al., 2009). The difference in the 327 
duration of shedding may be explained by the lower M. hyopneumoniae load in naturally 328 
infected gilts under field conditions compared to experimental conditions, where the 329 
bacterial load administered endo-tracheally might be much higher. Moreover, given the 330 
limited number of samplings over time of this study, the proposed timings about M. 331 
hyopneumoniae infection dynamics within this breeding herd should be considered as an 332 
estimation. Further research is needed to gain insight into infection dynamics of gilts 333 
under field conditions. 334 
Previous studies have suggested that M. hyopneumoniae piglet colonization at 335 
weaning is correlated with respiratory disease and lung lesions at fattening stages (Fano 336 
et al., 2007; Sibila et al., 2007). However, in the present field study, M. hyopneumoniae 337 
gilt shedding one week prior to farrowing (34 wpe) was not detected by rt-PCR and all 338 
piglets  from vaccinated and non-vaccinated gilts were rt-PCR negative. Thus, association 339 
between gilt shedding at farrowing and piglet colonization at weaning could not be 340 
assessed. Obtained results are in agreement with previous studies with similar M. 341 
hyopneumoniae infection dynamics in which piglets were also negative at weaning 342 
(Takeuti et al., 2017a, 2017b). 343 
Taking all these results together, the usage of two or four vaccination dose 344 
protocols in gilts seemed to be effective strategies for decreasing M. hyopneumoniae 345 
shedding and infectious pressure within a farm. Furthermore, results using four doses 346 
were slightly better (from a numeric point of view) than using two doses regarding 347 
ELISA results. Notwithstanding, these differences were only statistically significant in 348 
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terms of PI at 14 wpe, suggesting that vaccination with these two extra doses is not 349 
apparently justified from an infection and seroconversion points of view. Moreover, 350 
further studies are needed to compare these two doses with one dose.  351 
 The intra-farm genetic diversity of M. hyopneumoniae has been previously 352 
described using different methods and bacterium loci and thus, results are diverse. 353 
Several studies described a high intra-farm genetic diversity (Stakenborg., 2006; Nathues 354 
et al., 2011; dos Santos et al., 2015; Tamiozzo et al., 2015; Michiels et al., 2017;  Takeuti 355 
et al., 2017a) whereas others concluded that the variability was limited within the same 356 
farm (Stakenborg et al., 2005; Mayor et al., 2007, 2008; Vranckx et al., 2012; Charlebois 357 
et al., 2014; Galina-Pantoja L. et al., 2016). Results from the current study showed high 358 
M. hyopneumoniae variability within the farm. In the previous gilts batches (FS1 and 359 
FS2), higher variability was detected compared to monitored gilts at 14 wpe. Despite 360 
variants being different, similarity between TP 8 from FS2 and the more prevalent variant 361 
at 14 wpe (TP 10) might indicate that TP 10 was the result of mutations for each loci 362 
along this study. These findings are in agreement with previous reports that concluded 363 
that Mollicutes can exhibit high mutation and recombination rates by modification of 364 
environmental conditions (Razin et al., 1998). Furthermore, this similarity also suggests 365 
that the source of infection of gilts included in the study at entry was the own 366 
replacement (infected already based on data from FS1 and FS2) located in the same 367 
GDU. Unfortunately, information about M. hyopneumoniae variants harboured by own 368 
replacement over time was not assessed in the present study. Finally, analysing the 369 
VNTR obtained per locus, results of P97 and P146 loci are in accordance with previously 370 
published reports in which Spanish M. hyopneumoniae strains showed approximately 20 371 
repeats in P97 and more than 30 repeats in P146 (dos Santos et al., 2015). No previous 372 
data regarding VNTR for H1 are available. 373 
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In conclusion, the present study showed that M. hyopneumoniae gilt vaccination at 374 
acclimation period significantly reduced the M. hyopneumoniae shedding of gilts at 14 375 
wpe and increased antibody levels (low PI) of dams and their piglets. Since M. 376 
hyopneumoniae shedding in gilts was not detected at 34 wpe, the lack of bacterial piglet 377 
colonization was expectable. Despite the fact that M. hyopneumoniae vaccination does 378 
not provide full protection, the infectious pressure within the gilt population of the 379 
studied herd was significantly reduced. Gilt vaccination protocol with four doses showed 380 
slightly better numerical results than the protocol with two doses during all study. 381 
Therefore, these results suggested that the vaccination with two doses seems to be 382 
sufficient to reduce the infectious pressure and to induce strong and humoral immune 383 
response in gilts. Based on obtained results, a higher number of vaccine doses does not 384 
seem to be justified. Finally, the characterization of M. hyopneumoniae strains confirmed 385 
high genetic variability of this bacterium within the studied farm.  386 
387 
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Tables 
Table 1. Vaccination schedules against M. hyopneumoniae performed during the gilt 
acclimation period. 
Group 
name 
No. of gilts Vaccine doses 
Vaccination schedule 
2 wpe 4 wpe 6 wpe 8 wpe 
A 60 4 Hyogen® Hyogen® Hyogen® Hyogen® 
B 60 2 Hyogen® PBS Hyogen® PBS 
C 60 0 PBS PBS PBS PBS 
wpe: weeks post-entry; PBS: phosphate-buffered saline
21 
 
Table 2. Proportion (%) of M. hyopneumoniae seropositive gilts and piglets and median (range) of percentage of inhibition (PI) at different sampling points. 
Groups 
  
Sampling points 
1 wpe 
 
14 wpe 
 
27 wpe 
 
Prefarrowing (34 wpe) 
 
Piglets  
(at weaning) 
Prop 
(%) 
PI  
(Range)  
Prop 
(%) 
PI 
(Range)  
Prop (%) 
PI  
(Range)  
Prop 
(%) 
PI 
 (Range)  
Prop 
(%) 
PI  
(Range) 
A 
0/60  
0%a 
67.1 
(51.2-89.4)a 
  
60/60 
100%a 
4.8 
(3.1-19.8) a 
  
52/52 
100%a 
6.8 
(3.4-39.3)a 
  
49/49 
100%a 
5.7 
(3.6-17.8) a 
  
230/252 
91%a 
15.5 
(2.1-98.7)a 
B 
0/60 
0%a 
67.1 
(50.6-85.5)a  
60/60 
100%a 
5.5 
(3.7-13.5)b  
49/49 
100%a 
8.07 
(2.8-22.4)a  
47/47 
100%a 
6.2 
(4.0-36.6) a  
200/252 
79%a 
23.9 
(2.0-94.3)a 
C 
0/60 
0%a 
66.9 
(50.4-85.2)a 
  
59/60 
98%a 
14.3 
(3.3-53.2)c 
  
45/51 
88%b 
31.7 
(6.6-82.1)b 
  
44/50 
88% b 
28.7 
(5.0-61.8)b 
  
85/240 
35% b 
27.3 
(1.0-99.0)b 
Total 0/180 -  
179/180 
(99.4) 
-  
146/152 
(96.1) 
-  
140/146 
(95.9) 
-  
515/744 
(69.2) 
- 
wpe: week post-entry; Prop: Proportion; Range: minimum-maximum; Different superscripts within each column indicate significant differences among groups at different 
time points (p<0.05). 
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Table 3. Proportion (%) of M. hyopneumoniae rt-PCR positive gilts and piglets and Ct values at different sampling points of the study. 
Groups Sampling points 
 
1 wpe 
 
14 wpe 
 
27 wpe 
 
Prefarrowing (34 wpe) 
 
Piglets (at weaning) 
  
Prop  
(%) 
Ct range 
(Max – Min) 
  
Prop  
(%) 
Ct range 
(Min– Max) 
  
Prop 
(%) 
Ct range 
(Max – Min) 
  
Prop 
(%) 
Ct range 
(Max – Min) 
  
Prop  
(%) 
Ct range 
(Max – Min) 
A 
0/60 
0%a 
NA   
1/60 
2%a 
38.8-38.8 a    
0/52 
0%a 
NA   
0/49 
0%a 
NA   
0/252 
0%a 
NA 
B 
0/60 
0%a 
NA 
 
2/60 
3%a 
32.2-37.8a 
 
0/49 
0%a 
NA 
 
0/47 
0%a 
NA 
 
0/252 
0%a 
NA 
C 
0/60 
0% a 
NA   
27/60 
45%b 
29-1-38.7 a   
1/51 
2%a 
37.5-37.5   
0/50 
0%a 
NA   
0/240 
0%a 
NA 
wpe: week post-entry; Prop: Proportion; Na: Non-applicable; Different superscript within each column indicate significant differences among groups (p<0.05). Ct range has 
been calculated considering only rt-PCR positive animals. 
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Table 4. Variable number of tandem repeat (VNTR) profiles and typing profile (TP) in M. 
hyopneumoniae positive gilts using three loci. 
Sampling 
point 
Number of gilts 
carrying the 
variant (%) 
VNTR 
TP 
Group 
P97 P146 H1 Treatment n 
FS1 
1 (2.3) 11 38 6 1 
NA 10 
1 (2.3) 11 42 6 2 
2 (4.5) 11 45 6 3 
5 (11.3) 11 46 6 4 
1 (2.3) 11 47 6 5 
FS2 
1 (2.3) 11 22 4 6 
NA 9 
1 (2.3) 11 43 6 7 
5 (11.3) 11 46 6 4 
1 (2.3) 11 47 6 5 
1 (2.3) 9 22 6 8 
14 wpe 
1 (2.3) 9 20 4 9 C 1 
19 (43.2) 9 20 6 10 
B 
C 
2 
17 
4 (9.0) 9 20 7 11 C 4 
RF 1 (2.3) 14 21 10 RF NA 1 
Total 44 (100.0) NA NA NA 12 NA 44 
TP: Typing profile assigned; wpe: week post-entry; RF: Reference strain; NA: Non-applicable.  
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Figures 
 
 
 
 
Figure 1. Study design, housing location and sampling points of gilts and piglets included in the 
study. Housing sites are gilt development unit (GDU), detection and synchronization unit 
(DSU), gestation unit (GU) and farrowing unit (FU). Shapes represent gilt vaccination () and 
sampling points of gilts () at different weeks post-entry (wpe) into GDU indicated by 
numbers. Additionally, piglets () were sampled at weaning (equivalent to 38 wpe of gilts). 
 
                                       
                                       
GDU 
0    1     2     4      6      8                            14                                                           27                               34           38            
DSU GU FU 
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 1 
Figure 2. Percentages of inhibition (%) of gilts from groups A (), B () and C () at 1, 14, 27 2 
and 34 wpe; and from their piglets at weaning. Statistically significant differences (p<0.05) were 3 
observed between vaccinated (A and B) and non-vaccinated groups (C) (*) as well as among all 4 
three groups (**). The discontinuous line represents ELISA seropositivity threshold.  5 
6 
26 
 
 7 
Figure 3. Minimum spanning tree showing different M. hyopneumoniae variant profiles detected. 8 
RF: Reference strain 11 used as technique control. Each circle represents a variant profile. The 9 
size of the circle is proportional with the number of samples belonging to each variant profile. 10 
Absolute distances among variant profiles are represented by link label.  11 
 12 
 13 
14 
14 wpe 
FS1 
FS2 
RF 
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